🇺🇸 FDA
Pipeline program

Tinidazole oral microneedle patch

PGESCC001

Phase 3 other active

Quick answer

Tinidazole oral microneedle patch for Evaluate the DFS of Patients With Esophageal Cancer Who Underwent Radical Operation After Regular Removal of Porphyromonas Gingivalis is a Phase 3 program (other) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
First Tracks Biotherapeutics
Indication
Evaluate the DFS of Patients With Esophageal Cancer Who Underwent Radical Operation After Regular Removal of Porphyromonas Gingivalis
Phase
Phase 3
Modality
other
Status
active

Clinical trials